India Beats China at Its Own Game in Vaccine Diplomacy Fight

  • Despite its outbreak, Delhi has donated more jabs than Beijing
  • The competition is getting vaccines faster to poor countries
A employee stacks packed vials of Covishield, the local name for the vaccine developed by AstraZeneca, at the Serum plant in Maharashtra, on Jan. 22.Photographer: Dhiraj Singh/Bloomberg
Lock
This article is for subscribers only.

India’s huge capacity to make coronavirus vaccines is helping the country take on China in the battle to gain political influence across the developing world.

Competition among poorer nations to get cheap or free vaccines to fight the pandemic had given China a golden chance to strengthen ties in emerging markets it has been courting for years. And initially Beijing seemed in a strong position. It suppressed the domestic spread of Covid-19 last year and accelerated the production of shots.